Adar Poonawalla, CEO of Serum Institute of India (SII), exuded confidence in meeting the Centre’s goal of immunising all adults by yearend, while announcing that Covid-19 vaccine for children, Covavax, is readying for a February-March launch. The Pune-based company hopes to resume exports of its vaccine, Covishield to WHObacked global platform, Covax by November.
Adar Poonawalla, CEO of Serum Institute of India (SII), exuded confidence in meeting the Centre’s goal of immunising all adults by yearend, while announcing that Covid-19 vaccine for children, Covavax, is readying for a February-March launch. The Pune-based company hopes to resume exports of its vaccine, Covishield to WHObacked global platform, Covax by November. from Times of India https://ift.tt/3vAv7GE
Adar Poonawalla, CEO of Serum Institute of India (SII), exuded confidence in meeting the Centre’s goal of immunising all adults by yearend, while announcing that Covid-19 vaccine for children, Covavax, is readying for a February-March launch. The Pune-based company hopes to resume exports of its vaccine, Covishield to WHObacked global platform, Covax by November. from Times of India https://ift.tt/3vAv7GE
Comments
Post a Comment